<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000046176">
  <TermName>BMS-184476</TermName>
  <TermDefinition>
    <DefinitionText>A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called mitotic inhibitors.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <SpanishTermName>BMS-184476</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Sustancia en estudio para el tratamiento de cáncer. Es un tipo de inhibidor mitótico.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateLastModified>2003-10-15</DateLastModified>
</GlossaryTerm>
